Abstract
Purpose
The aim of this clinical study was to evaluate the level of Interleukine-6 (IL-6), pre and post arthrocentesis to validate it as a biomarker in the Internal Derangement (ID) of TMJ.
Material and Methods
This study included 30 patients (20 females and 10 males) of Temporo-Mandibular Dysfunction (TMD) with Disc displacement without reduction (DDwoR) Wilkes stage III, who were refractory to conservative management. Arthrocentesis was performed as a therapeutic modality. Synovial fluid aspirates were obtained prior to arthrocentesis and post arthrocentesis with 300 ml of Ringer Lactate solution into the superior joint compartment for the assessment of level of IL-6. The clinical parameters used for correlating the level of IL-6 were degree of pain (VAS I), chewing ability (VAS II), Maximal Mouth Opening (MMO) in both pre and post op phase with the follow-up period of 01 day, 01 week, 01 month, 03 month and 06 month and the results were compared. ELISA was performed to analyze the levels of IL-6 in the aspirates. The clinical parameters and the level of IL-6 were recorded and analyzed statistically.
Results
The study showed ID of TMJ (Wilkes stage III) s are more prevalent in females especially in the fourth decades of life with the mean age of 38.4 years. The post operative assessment in terms of pain, maximum mouth opening, lateral movements of the mandible and the levels of IL-6 were found to be statistically significant with a P value <0.01.
Conclusion
This study validates the role of IL-6 as a definitive biomarker for the pathogenesis of ID of TMJ Wilkes stage III and arthrocentesis proved to be a minimally invasive therapeutic modality for its management.
Similar content being viewed by others
References
Nishimura M, Segami N, Kaneyama K, Sato J, Fujimura K (2004) Comparison of cytokine level in synovial fluid between successful and unsuccessful cases in arthrocentesis of temporomandibular joint. J Oral Maxillofac Surg 62(3):284–287
Dorrit W, Nitzan DMD (2006) Arthrocentesisd incentives for using this minimally invasive approach for temporomandibular disorders. Oral Maxillofacial SurgClin N Am 18:311–328
Dolwick MF, Riggs RR (1983) Diagnosis and treatment of internal de-rangements of the temporomandibular joint. Dent Clin North Am 27:561–572
List T, Jensen RH (2017) Temporomandibular disorders: old ideas and new concepts. Cephalalgia 37:692–704
Giraddi GB, Siddaraju A, Kumar B, Singh C (2012) Internal derangement of temporomandibular joint: an evaluation of effect of corticosteroid injection compared with injection of sodium hyaluronate after arthrocentesis. J Maxillofac Oral Surg 11:258–263
Bhargava D, Jain M, Deshpande A, Singh A, Jaiswal J (2015) Temporomandibular joint arthrocentesis for internal derangement with disc displacement without reduction. J Maxillofac Oral Surg 14:454–459
Wilkes CH (1989) Internal derangements of the temporomandibular joint. Pathological variations. Arch Otolaryngol Head Neck Surg 115:469–477
Patel P, Idrees F, Newaskar V, Agrawal D (2016) Sodium hyaluronate: an effective adjunct in temporomandibular joint arthrocentesis. Oral Maxillofac Surg 20:405–410
Nan Z, Guoliang J, Zhongyin W (2015) Clinical symptoms and temporomandibular joint disc deformity study of Wilkes III stage patients treated with arthrocentesis. West Chin J Stomatol 33:585–588
Emes Y, Arpınar IŞ, Oncü B, Aybar B, Aktaş I, Al Badri N, Atalay B, Issever H, Yalcin S (2014) The next step in the treatment of persistent temporomandibular joint pain following arthrocentesis: a retrospective study of 18 cases. J Craniomaxillofac Surg 42:e65–e69
Leibur E, Jagur O, Voog-Oras Ü (2015) Temporomandibular joint arthrocentesis for the treatment of osteoarthritis. Stomatologija 17:113–117
Diraçoğlu D, Saral IB, Keklik B, Kurt H, Emekli U, Ozçakar L, Karan A, Aksoy C (2009) Arthrocentesis versus nonsurgical methods in the treatment of temporomandibular disc displacement without reduction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108:3–8
Talaat W, Ghoneim MM, Elsholkamy M (2016) Single-needle arthrocentesis (Shepard cannula) vs. double-needle arthrocentesis for treating disc displacement without reduction. Cranio 34:296–302
Nitzan DW, Samson B, Better H (1997) Long-term outcome of arthrocentesis for sudden-onset, persistent, severe closed lock of the temporomandibular joint. J Oral Maxillofac Surg 55:151–157
Murakami K, Hosaka H, Moriya Y, Segami N, Iizuka T (1995) Short-term treatment outcome study for the management of temporomandibular joint closed lock. A comparison of arthrocentesis to nonsurgical therapy and arthroscopic lysis and lavage. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 80:253–257
Sembronio S, Albiero AM, Toro C, Robiony M, Politi M (2008) Is there a role for arthrocentesis in recapturing the displaced disc in patients with closed lock of the temporomandibular joint? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:274–280
Dimitroulis G, Dolwick MF, Martinez A (1995) Temporomandibular joint arthrocentesis and lavage for the treatment of closed lock: a follow up study. Br J Oral Maxillofac Surg 33:23–26
David Frost E, Barry Kendell D (1999) The use of arthrocentesis for treatment of temporomandibular joint disorders. J Oral Maxillofac Surg 57:583–587
Monje-Gil F, Nitzan D, Gonzalez-Garcia R (2012) Temporomandibular joint arthrocentesis. Review of the literature. Med Oral Patol Oral Cir Bucal. 17(4):e575–e581
Feghali CA, Wright TM (1997) Cytokines in acute and chronic inflammation. Front Biosci 2:d12-26
Campos MIG, Campos PSF, Line SRP (2006) Inflammatory cytokines activity in temporomandibular joint disorders: a review of literature. Braz J Oral Sci 5:1054–1062
Gunson MJ, Arnett GW, Milam SB (2012) Pathophysiology and pharmacologic control of osseous mandibular condylar resorption. J Oral Maxillofac Surg. 70(8):1918–1934
Fu K, Ma X, Zhang Z, Pang X, Chen W (1995) Interleukin-6 in synovial fluid and HLADR expression in synovium from patients with temporomandibular disorders. J Orofac Pain 9:131–137
Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C (2003) IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol 24:25–29
Yamamoto M, Yoshizaki K, Kishimoto T, Ito H (2000) IL-6 is required for the development of Th-1 cell-mediated murine colitis. J Immunol 164:4878–4882
Watanabe S, Ogura N, Akutsu M, Kawashima M, Hattori T, Yano T, Ito K, Kondoh T (2017) Pro-inflammatory cytokine production in co-culture of human monocytes and synovial fibroblasts from the human temporomandibular joint. Int J Oral Med Sci 15:107–113
Xiong H, Li W, Li J, Fang W, Ke J, Li B, Cheng Y, Wei L (2019) Elevated leptin levels in temporomandibular joint osteoarthritis promote pro-inflammatory cytokine IL-6 expression in synovial fibroblasts. J Oral Pathol Med 48:251–259
Takahashi T, Kondoh T, Fukuda M, Yamazami Y, Toyosaki T, Suzuki R (1998) Proinflammatory cytokines detactable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:135–141
Yang MC, Wang DH, Wu HT, Li WC, Chang TY, Lo WL, Hsu ML (2019) Correlation of magnetic resonance imaging grades with cytokine levels of synovial fluid of patients with temporomandibular jointdisorders: a cross-sectional study. Clin Oral Investig 23:3871–3878
Keun JL, Sook YC, Song S (2010) Relationship of synovial tumor necrosis factor-alpha and interleukin 6 to temporomandibular disorder. J Oral Maxillofac Surg 68:1064–1068
Kristensen KD, Alstergren P, Stoustrup P, Küseler A, Herlin T, Pedersen TK (2014) Cytokines in healthy temporomandibular joint synovial fluid. J Oral Rehabil 41(4):250–256
Kim YK, Kim SG, Kim BS, Lee JY, Yun PY, Bae JH, Oh JS, Ahn JM, Kim JS, Lee SY (2012) Analysis of the cytokine profiles of the synovial fluid in a normal temporomandibular joint: preliminary study. J Cranio-Maxillofac Surg 40:e337–e341
Kuboto E, Kubota T, Matsumoto J, Shibata T, Murakami KI (1998) Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 56:192–198
Matsumoto K, Honda K, Ohshima M, Yamaguchi Y, Nakajima I, Micke P, Otsuka K (2006) Cytokine profile in synovial fluid from patients with internal derangement of the temporomandibular joint: a preliminary study. DentomaxilRadiol. 35:432–441
Kellesarian SV, Al-Kheraif AA, Vohra F, Ghanem A, Malmstrom H, Romanos GE, Javed F (2016) Cytokine profile in the synovial fluid of patients with temporomandibular joint disorders: a systematic review. Cytokine 77(1):98–106
Wake M, Hamada Y, Kumagai K, Tanaka N, Ikeda Y, Nakatani Y, Suzuki R, Fukui N (2013) Up-regulation of interleukin-6 and vascular endothelial growth factor: a in the synovial fluid of temporomandibular joints affected by synovial chondromatosis. Br J Oral Maxillofac Surg 51:164–169
Gulen H, Ataoglu H, Haliloglu S, Isik K (2009) Proinflammatory in temporomandibular joint synovial fluid before and after arthrocentesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 7(5):1–4
Gozal D (2012) Serum, urine, and breath-related biomarkers in the diagnosis of obstructive sleep apnea in children: Is it for real? Curr Opin Pulm Med 18:561–567
Mayeux R (2004) Biomarkers: potential uses and limitations. NeuroRx 1:182–188
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Balasundaram, T., Roy Chowdhury, S.K., Chattopadhyay, P.K. et al. Validity of IL-6 and Arthrocentesis in the Cause and Management of Internal Derangement of TMJ. J. Maxillofac. Oral Surg. 21, 1209–1217 (2022). https://doi.org/10.1007/s12663-021-01533-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12663-021-01533-0